Diabetes

Featured Article
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says…
VA Diabetes Risk Cohort Provides Largest Pool of US Adults Without Diabetes at Baseline
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic…

Newsfeed

Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
VA Diabetes Risk Cohort Provides Largest Pool of US Adults Without Diabetes at Baseline
Continuous Diffusion of Oxygen Therapy Cost-Effective for Advanced Diabetic Foot Ulcers
Study Finds Higher 5-Year Costs With Semaglutide Instead of Sitagliptin for Type 2 Diabetes
Diabetes Increases Readmission Risk After Elective Total Joint Arthroplasty
SGLT2 Inhibitors Estimated to Be Cost-Effective for Type 2 Diabetes
Physician-Pharmacist Collaboration Improves Diabetes Outcomes, Reduces Costs
View More

Insights

Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh, consultant…
Implementing Patient Education Strategies to Help Patients in Reducing or Preventing the Incidence of Prediabetes, Type 2 Diabetes
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
Barriers to Diabetes Treatment Linked With Increased Monthly Costs
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of diabetes…
View More

Interactive Features

Examining a Treatment Option for Veterans With Diabetes, Foot Ulcers
Bob Maguire, BioLab Sciences, and Charles Pollak, Red One Medical, discuss their recent partnership and highlight a treatment option for veterans with diabetic foot ulcers, which impacts roughly 75,000 veterans.
How Hepatitis C Treatment Success Relates to Insulin Resistance
Does hepatitis C treatment success improve insulin resistance in patients with diabetes?
View More
Back to Top